Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://jadahmyj004427.bloggerswise.com/47028031/retaglutide-a-promising-glp-1-receptor-agonist